News Singular Genomics Systems, Inc.

Equities

OMIC

US82933R1005

Market Closed - Nasdaq Other stock markets 02:00:01 11/05/2024 am IST			5-day change	1st Jan Change
0.4118 ^USD	-8.06%		-0.31%	-10.50%

20/03	UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating	MT
18/03	Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024	02/05	GL
UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating	20/03	MT
Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024	19/03
Similar Genomics Systems: Q4 Earnings Snapshot	19/03	AQ
Earnings Flash (OMIC) SINGULAR GENOMICS SYSTEMS Posts Q4 Revenue $1.1M, vs. Street Est of $1.04M	19/03	MT
Singular Genomics Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03	CI
Singular Genomics Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	19/03	CI
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results	19/03	GL
North American Morning Briefing : Investors -2-	18/03	DJ
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024	05/03	GL
Transcript : Singular Genomics Systems, Inc. - Special Call	05/02
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform	05/02	GL
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis	05/02	GL
Singular Genomics Systems, Inc. Showcases New G4X? Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4 Sequencing Platform	05/02	CI
Singular Genomics Unveils G4X Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis	05/02	CI
Goldman Sachs Trims Price Target on Singular Genomics Systems to $0.85 From $0.95, Maintains Neutral Rating	22/01	MT
Singular Genomics Systems, Inc. Provides Unaudited Revenue Guidance for the Fourth Quarter of 2023	08/01	CI
Singular Genomics Systems Expects 31% Growth in Q4 Revenue	08/01	MT
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue	08/01	AQ
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue	08/01	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Singular Genomics Systems, Inc.

Equities

OMIC

US82933R1005

Summary

Filters